Donald L. Loriaux

Donald L. Loriaux's AcademicInfluence.com Rankings

Donald L. Loriaux

Philosophy

#4157

World Rank

#6563

Historical Rank

Logic

#1678

World Rank

#2492

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Donald L. Loriaux Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Donald L. Loriaux's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. (1991) (778)
Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications. (1986) (738)
Acute hypothalamic-pituitary-adrenal responses to the stress of treadmill exercise. Physiologic adaptations to physical training. (1987) (508)
Psychiatric implications of basic and clinical studies with corticotropin-releasing factor. (1984) (458)
Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. (1991) (449)
Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa. Pathophysiologic mechanisms in underweight and weight-corrected patients. (1986) (411)
Hormones, emotional dispositions, and aggressive attributes in young adolescents. (1987) (353)
Perioperative Glucocorticoid Coverage A Reassessment 42 Years After Emergence of a Problem (1994) (341)
Adrenarche: a survey of rodents, domestic animals, and primates. (1978) (329)
The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome. (1984) (318)
Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486. (1985) (313)
Hypothalamic dysfunction in secondary amenorrhea associated with simple weight loss. (1977) (290)
Preoperative lateralization of ACTH-secreting pituitary microadenomas by bilateral and simultaneous inferior petrosal venous sinus sampling. (1985) (275)
Responses of the hypothalamic-pituitary-adrenal and renin-angiotensin axes and the sympathetic system during controlled surgical and anesthetic stress. (1987) (274)
Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty. (1981) (263)
Primary cortisol resistance in man. A glucocorticoid receptor-mediated disease. (1982) (239)
The secretion of dehydroepiandrosterone and dehydroepiandrosterone sulphate in man. (1973) (218)
Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. A preliminary report. (1981) (217)
A simplified morning ovine corticotropin-releasing hormone stimulation test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. (1993) (216)
Hypothalamic dysfunction in patients with anorexia nervosa. (1974) (202)
A preliminary study of the effect of estrogen dose on growth in Turner's syndrome. (1983) (200)
Human corticotropin-releasing factor in man: pharmacokinetic properties and dose-response of plasma adrenocorticotropin and cortisol secretion. (1984) (198)
Repeat transsphenoidal surgery for Cushing's disease. (1989) (190)
Adaptation during surgical stress. A reevaluation of the role of glucocorticoids. (1986) (188)
Responses of plasma adrenocorticotropin, cortisol, and dehydroepiandrosterone to ovine corticotropin-releasing hormone in healthy aging men. (1986) (182)
Cortisol production rate in childhood and adolescence. (1990) (182)
Radioimmunoassay for Plasma Testosterone (1972) (181)
The NIH experience with precocious puberty: diagnostic subgroups and response to short-term luteinizing hormone releasing hormone analogue therapy. (1986) (179)
The measurement of estrone sulfate in plasma. (1971) (178)
Premature thelarche and central precocious puberty: the relationship between clinical presentation and the gonadotropin response to luteinizing hormone-releasing hormone. (1988) (177)
Glucocorticoid hormone resistance during primate evolution: receptor-mediated mechanisms. (1982) (175)
The ovine corticotropin-releasing hormone stimulation test and the dexamethasone suppression test in the differential diagnosis of Cushing's syndrome. (1986) (174)
Association of 24-hour cortisol production rates, cortisol-binding globulin, and plasma-free cortisol levels with body composition, leptin levels, and aging in adult men and women. (2004) (169)
EFFECTS OF HUMAN PANCREATIC TUMOUR GROWTH HORMONE RELEASING FACTOR ON GROWTH HORMONE AND SOMATOMEDIN C LEVELS IN PATIENTS WITH IDIOPATHIC GROWTH HORMONE DEFICIENCY (1983) (165)
Studies of the role of sex steroids in the feedback control of FSH concentrations in men. (1973) (164)
Urine free cortisol in the high-dose dexamethasone suppression test for the differential diagnosis of the Cushing syndrome. (1992) (161)
Hormonal and metabolic responses of untrained, moderately trained, and highly trained men to three exercise intensities. (1989) (159)
Gadolinium DTPA enhanced MR imaging of ACTH-secreting microadenomas of the pituitary gland. (1988) (157)
Growth hormone secretory dynamics in Turner syndrome. (1985) (156)
Dose-response relationships for the effects of growth hormone-releasing factor-(1-44)-NH2 in young adult men and women. (1984) (153)
Pituitary adenomas in patients with Cushing disease: initial experience with Gd-DTPA-enhanced MR imaging. (1987) (152)
Spironolactone and endocrine dysfunction. (1976) (145)
Cimetidine is an antiandrogen in the rat. (1979) (140)
A double-blind study of perioperative steroid requirements in secondary adrenal insufficiency. (1997) (139)
Developmental processes in early adolescence: relationships between adolescent adjustment problems and chronologic age, pubertal stage, and puberty-related serum hormone levels. (1987) (137)
The effect of estradiol on testicular testosterone biosynthesis. (1980) (136)
Late-onset 21-hydroxylase deficiency mimicking idiopathic hirsutism or polycystic ovarian disease. (1982) (134)
Human platelet monoamine oxidase changes during the menstrual cycle. (1974) (132)
Estrone sulfate, estrone, estradiol and estriol plasma levels in human pregnancy. (1972) (131)
Plasma estrone, prolactin, neurophysin, and sex steroid-binding globulin in chronic alcoholic men. (1975) (131)
True precocious puberty complicating congenital adrenal hyperplasia: treatment with a luteinizing hormone-releasing hormone analog. (1984) (131)
Petrosal sinus sampling for Cushing syndrome: anatomical and technical considerations. Work in progress. (1984) (130)
The thymus-adrenal connection: thymosin has corticotropin-releasing activity in primates. (1983) (124)
The developmental changes in plasma adrenal androgens during infancy and adrenarche are associated with changing activities of adrenal microsomal 17-hydroxylase and 17,20-desmolase. (1981) (118)
The corticotropin-releasing hormone test in the postoperative evaluation of patients with cushing's syndrome. (1987) (115)
Mechanisms of Physical and Emotional Stress (1988) (111)
Clinical Applications of Corticotropin-Releasing Factor (1985) (111)
Improved Quality of Life After Bilateral Laparoscopic Adrenalectomy for Cushing's Disease: A 10-Year Experience (2007) (110)
Treatment of familial male precocious puberty with spironolactone and testolactone. (1989) (108)
The corticotropin-releasing hormone stimulation test: a possible aid in the evaluation of patients with adrenal insufficiency. (1984) (107)
Morphine inhibits the pituitary-adrenal response to ovine corticotropin-releasing hormone in normal subjects. (1985) (105)
Enhanced cortisol production rates, free cortisol, and 11beta-HSD-1 expression correlate with visceral fat and insulin resistance in men: effect of weight loss. (2009) (105)
The relation of relative hormonal levels and physical development and social-emotional behavior in young adolescents (1985) (105)
Studies on the role of sex steroids in the feedback control of gonadotropin concentrations in men. II. Use of the estrogen antagonist, clomiphene citrate. (1979) (104)
Cushing syndrome due to primary pigmented nodular adrenocortical disease: findings at CT and MR imaging. (1989) (103)
Continuous administration of synthetic ovine corticotropin-releasing factor in man. Physiological and pathophysiological implications. (1985) (103)
Evidence for a critical role of progesterone in the regulation of the midcycle gonadotropin surge and ovulation. (1992) (102)
Delayed pituitary hormone response to LRF and TRF in patients with anorexia nervosa and with secondary amenorrhea associated with simple weight loss. (1976) (101)
Developmental processes in early adolescence. Relations among chronologic age, pubertal stage, height, weight, and serum levels of gonadotropins, sex steroids, and adrenal androgens. (1987) (100)
Short term, low dose estradiol accelerates ulnar growth in boys. (1985) (99)
The evolution of societies (1991) (98)
Effects of a growth hormone releasing factor in man. (1983) (96)
Interaction of digitalis and spironolactone with human sex steroid receptors. (1978) (93)
Growth hormone (GH) responses to GH-releasing hormone during pubertal development in normal boys and girls: comparison to idiopathic short stature and GH deficiency. (1986) (93)
Macronodular adrenal hyperplasia in Cushing disease. (1988) (93)
Long-acting gonadotropin hormone-releasing hormone analog used to treat uteri. (1986) (92)
Behavior problems and social competence in girls with true precocious puberty. (1985) (91)
Steroidogenic enzyme activities, morphology, and receptor studies of a testicular adrenal rest in a patient with congenital adrenal hyperplasia. (1990) (90)
Mitotane enhances cytotoxicity of chemotherapy in cell lines expressing a multidrug resistance gene (mdr-1/P-glycoprotein) which is also expressed by adrenocortical carcinomas. (1991) (90)
Developmental changes in neuroendocrine regulation of gonadotropin secretion in gonadal dysgenesis. (1983) (89)
Resumption of puberty after long term luteinizing hormone-releasing hormone agonist treatment of central precocious puberty. (1988) (89)
Effect of spironolactone on sex hormones in man. (1975) (88)
Effect of low doses of estradiol on 6-month growth rates and predicted height in patients with Turner syndrome. (1986) (88)
Effect of the antiprogestin RU486 on progesterone production by cultured human granulosa cells: inhibition of the ovarian 3B-hydroxysteroid dehydrogenase. (1986) (86)
Localization of GRF-like immunoreactive neurons in the rat brain (1983) (85)
Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone. (1986) (85)
Evidence that testosterone can suppress pituitary gonadotropin secretion independently of peripheral aromatization. (1979) (85)
Vertebral body bone mineral content in hyperprolactinemic women. (1984) (85)
Dissociation of cortisol and adrenal androgen secretion in patients with secondary adrenal insufficiency. (1979) (84)
The incidental adrenal mass. (1996) (82)
Plasma cortisol transport and primate evolution. (1984) (82)
Severe osteopenia in young adults associated with Cushing's syndrome due to micronodular adrenal disease. (1974) (81)
The relationship of saline-induced changes in vasopressin secretion to basal and corticotropin-releasing hormone-stimulated adrenocorticotropin and cortisol secretion in man. (1987) (79)
Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa. (1986) (79)
Differentiation of adrenal masses by magnetic resonance imaging. (1987) (79)
The effect of mevinolin on steroidogenesis in patients with defects in the low density lipoprotein receptor pathway. (1987) (77)
Corticotropin-releasing factor: pharmacokinetics in man. (1984) (75)
The effects of corticotropin releasing factor on the anterior pituitary function of stalk-sectioned cynomolgus macaques: dose response of cortisol secretion. (1982) (75)
Effect of chronic treatment with the glucocorticoid antagonist RU 486 in man: toxicity, immunological, and hormonal aspects. (1990) (74)
Intracerebroventricular corticotropin-releasing factor increases limbic glucose metabolism and has social context-dependent behavioral effects in nonhuman primates (2002) (72)
Absence of pubertal gonadotropin secretion in girls with McCune-Albright syndrome. (1984) (72)
Predominant involvement of mu- rather than delta- or kappa-opiate receptors in LH secretion (1983) (71)
Cavernous sinus sampling is highly accurate in distinguishing Cushing's disease from the ectopic adrenocorticotropin syndrome and in predicting intrapituitary tumor location. (1999) (70)
Studies on the role of sex steroids in the feedback control of gonadotropin concentrations in men. III. Androgen resistance in primary gonadal failure. (1979) (70)
Receptor-mediated effects of glucocorticoids on inflammation: enhancement of the inflammatory response with a glucocorticoid antagonist. (1988) (70)
The ovine corticotropin-releasing hormone (CRH) stimulation test is superior to the human CRH stimulation test for the diagnosis of Cushing's disease. (1989) (69)
Anorexia nervosa: behavioural and hypothalamic aspects. (1976) (67)
Effects of pulsatile administration of growth hormone (GH)-releasing hormone on short term linear growth in children with GH deficiency. (1985) (67)
Catecholamine-glucocorticoid interactions during surgical stress. (1987) (66)
A dispersed-whole cell method for the determination of androgen receptors in human skin fibroblasts (1980) (66)
Ovine corticotropin-releasing factor administration in normal men. Pituitary and adrenal responses in the morning and evening. (1985) (65)
Solid phase method for measurement of the binding capacity of testosterone-estradiol binding globulin in human serum (1978) (64)
Pulsatile administration of human corticotropin-releasing hormone in patients with secondary adrenal insufficiency: restoration of the normal cortisol secretory pattern. (1986) (64)
Interaction of epidermal growth factor with the hypothalamic-pituitary-adrenal axis: potential physiologic relevance. (1988) (63)
Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: a potential new contraceptive strategy. (1992) (63)
Andrenarche and its relationship to the onset of puberty. (1980) (63)
Adaptation of the mineralocorticoid target tissues to the high circulating cortisol and progesterone plasma levels in the squirrel monkey. (1984) (63)
Relative binding of testosterone and estradiol to testosterone-estradiol-binding globulin. (1979) (62)
Studies on the transfer of steroid hormones across the blood-cerebrospinal fluid barrier in the Rhesus Monkey. (1976) (62)
Pharmacologic suppression of the fetal adrenal gland in utero. Attempted prevention of abnormal external genital masculinization in suspected congenital adrenal hyperplasia. (1985) (60)
Cushing syndrome: pituitary CT scanning. (1987) (59)
Direct administration of testosterone increases rat tibial epiphyseal growth plate width. (1989) (58)
CT of cerebral abnormalities in precocious puberty. (1987) (58)
Daily rhythm of plasma melatonin in normal and precocious puberty. (1982) (58)
Mechanisms of corticosteroid action on lymphocyte subpopulations. VI. Lack of correlation between glucocorticosteroid receptors and the differential effects of glucocorticosteroids on T-cell subpopulations. (1980) (57)
Adrenocorticotropin-stimulated adrenal androgen secretion in anorexia nervosa: impaired secretion at low weight with normalization after long-term weight recovery. (1985) (57)
Six-year results of luteinizing hormone releasing hormone (LHRH) agonist treatment in children with LHRH-dependent precocious puberty. (1989) (57)
Interaction of spironolactone and digitalis with the 5 alpha-dihydrotestosterone (DHT) receptor of rat ventral prostate. (1975) (56)
Pharmacokinetic properties of the antiglucocorticoid and antiprogesterone steroid RU 486 in man. (1987) (56)
Dissociation of adrenarche and gonadarche in precocious puberty and in isolated hypogonadotropic hypogonadism. (1987) (56)
Primary cortisol resistance presenting as isosexual precocity. (1990) (56)
Estrogen receptor in rat adrenal gland. (1978) (56)
Glucocorticoid resistance in humans and nonhuman primates. (1989) (56)
Testosterone-estradiol binding globulin binds to 2-methoxyestradiol with greater affinity than to testosterone. (1980) (55)
Luteinizing hormone-releasing hormone analog treatment of boys with hypothalamic hamartoma and true precocious puberty. (1984) (54)
Usefulness of inferior petrosal sinus venous endocrine markers in Cushing's disease. (1988) (54)
Leydig cell function in men with disorders of spermatogenesis. (1974) (53)
Mechanism of interaction of digitalis with estradiol binding sites in rat uteri. (1976) (53)
Pituitary-adrenal responsiveness to corticotropin-releasing hormone in patients receiving chronic, alternate day glucocorticoid therapy. (1985) (52)
The effects of sex steroids on ulnar growth during adolescence. (1984) (52)
Central kappa- and mu-opiate receptors mediate ACTH-release in rats. (1985) (51)
Petrosal sinus sampling: discordant lateralization of ACTH-secreting pituitary microadenomas before and after stimulation with corticotropin-releasing hormone. (1990) (51)
Efficacy of a gonadotropin-releasing hormone agonist in the treatment of uterine leiomyomata: long-term follow-up. (1989) (51)
Genetic variation of the glucocorticoid receptor from a steroid-resistant primate. (1991) (51)
Diagnosis and Differential Diagnosis of Cushing's Syndrome. (2017) (51)
The mechanism of hypercortisolemia in the squirrel monkey. (1982) (50)
Marijuana: interaction with the estrogen receptor. (1983) (50)
Growth hormone secretory dynamics in children with precocious puberty. (1987) (49)
Somatomedin-C in accelerated growth of children with precocious puberty. (1985) (49)
Radioligand assay for 5 -3 -hydroxysteroids. I. 3 -Hydroxy-5-androstene-17-one and its 3-sulfate. (1972) (49)
Sensitivity of cortisol and adrenal androgens to dexamethasone suppression in hirsute women. (1985) (49)
The Effects of N,N-Diethyl-4-Methyl-3-Oxo-4-Aza-5α-Androstane-17yβ-Carboxamide, a 5α-Reductase Inhibitor and Antiandrogen, on the Development of Baldness in the Stumptail Macaque (1987) (49)
The defective glucocorticoid receptor in man and nonhuman primates. (1985) (49)
Hemodynamic effects of corticotropin releasing hormone in the anesthetized cynomolgus monkey (1986) (48)
Ovarian Function in Girls with McCune-Albright Syndrome (1986) (48)
Primary cortisol resistance: a family study. (1983) (47)
Cyclical ovarian function resistant to treatment with an analogue of luteinizing hormone releasing hormone in McCune-Albright syndrome. (1984) (47)
Suppression of plasma luteinizing hormone by prolactin in the male rat. (1978) (47)
Effect of fluoxymesterone on the pituitary-gonadal axis: the role of testosterone-estradiol-binding globulin. (1976) (47)
Variable response to a long-acting agonist of luteinizing hormone-releasing hormone in girls with McCune-Albright syndrome. (1984) (47)
The antiprogestin RU486 delays the midcycle gonadotropin surge and ovulation in gonadotropin-releasing hormone-induced cycles. (1994) (46)
Testicular volume during early infancy. (1981) (46)
The effect of serum prolactin on plasma adrenal androgens and the production and metabolic clearance rate of dehydroepiandrosterone sulfate in normal and hyperprolactinemic subjects. (1986) (46)
The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man. (1988) (45)
Cortisol production rate measurement by stable isotope dilution using gas chromatography-negative ion chemical ionization mass spectrometry1 (1999) (45)
Primary Pigmented Nodular Adrenocortical Disease: A Light and Electron Microscopic Study of Eight Cases (1989) (45)
Glucocorticoids and glucocorticoid antagonists: lessons from RU 486. (1988) (44)
Rapid metabolic clearance of the catechol estrogen 2-hydroxyestrone. (1980) (44)
A seminiferous tubular factor is not obligatory for regulation of plasma follicle-stimulating hormone in the rat. (1981) (44)
Cushing's syndrome and the nodular adrenal gland. (1994) (43)
Hormonal responses to the stress of exercise. (1988) (43)
Uterine estrogen and progesterone receptors in an estrogen- and progesterone- "resistant" primate. (1984) (43)
Dissociation of cortisol and adrenal androgen secretion in the hypophysectomized, adrenocorticotropin-replaced chimpanzee. (1984) (42)
Pubertal endocrinology of the baboon: adrenarche. (1981) (42)
Developmental changes in rabbit and dog adrenal function: a possible homologue of adrenarche in the dog. (1981) (42)
Precocious puberty associated with neurofibromatosis and optic gliomas. Treatment with luteinizing hormone releasing hormone analogue. (1985) (42)
Plasma testosterone in homosexual and heterosexual women. (1977) (42)
Androgen binding proteins of testis, epididymis, and plasma in man and monkey. (1976) (41)
Growth hormone responses to continuous infusions of growth hormone-releasing hormone. (1985) (41)
Effect of continuous somatostatin and growth hormone-releasing hormone (GHRH) infusions on the subsequent growth hormone (GH) response to GHRH. Evidence for somatotroph desensitization independent of GH pool depletion. (1987) (41)
Luteinizing Hormone Releasing Hormone Analogue Therapy for Central Precocious Puberty: Long-term Effect on Somatic Growth, Bone Maturation, and Predicted Height (1986) (40)
Evidence for Leydig cell dysfunction in infertile men with a selective increase in plasma follicle-stimulating hormone. (1987) (40)
Late-onset 21-hydroxylase deficiency is an allelic variant of congenital adrenal hyperplasia characterized by attenuated clinical expression and different HLA haplotype associations. (1982) (40)
Effect of bromocriptine on affect and libido in hyperprolactinemia. (1987) (39)
The squirrel monkey: receptor-mediated end-organ resistance to progesterone? (1982) (39)
Metabolism of exogenous 4- and 2-hydroxyestradiol in the human male. (1986) (39)
The effect of pubertal delay on adult height in men with isolated hypogonadotropic hypogonadism. (1992) (39)
Cortisol production rate in posttraumatic stress disorder. (2006) (38)
Global clinical response in Cushing’s syndrome patients treated with mifepristone (2014) (38)
An approach to the patient with hirsutism. (2012) (38)
Ovine corticotropin-releasing hormone stimulation test in normal children. (1986) (38)
The new world primates as animal models of glucocorticoid resistance. (1986) (38)
Resistance to several steroids in two sisters. (1999) (38)
Failure of endogenous prolactin to alter renal salt and water excretion and adrenal function in man. (1976) (38)
Metabolic clearance rate and plasma half-life of radioiodinated corticotropin releasing factor in a primate. (1982) (37)
Glucocorticoid receptor in circulating mononuclear leukocytes. (1979) (37)
Primary Adrenal Causes of Cushing's Syndrome; Diagnosis and Surgical Management (1989) (36)
Rat adrenal androgen receptor: a possible mediator of androgen-induced decreased in rat adrenal weight. (1978) (36)
Stable isotope dilution method using thermospray liquid chromatography/mass spectrometry for quantification of daily cortisol production in humans. (1988) (36)
Steroid Hormone Resistance (1986) (36)
Radioimmunoassay and metabolism of the catechol estrogen 2-hydroxyestradiol. (1982) (36)
New evidence for a direct effect of prolactin on rat adrenal steroidogenesis. (1987) (35)
Unilateral testicular enlargement resulting from inapparent 21-hydroxylase deficiency. (1981) (35)
Evidence for an adrenal origin of plasma estrogens in alcoholic men. (1979) (35)
Glucocorticoid receptors in Epstein-Barr virus-transformed lymphocytes from patients with glucocorticoid resistance and a glucocorticoid-resistant New World primate species. (1986) (34)
Primary cortisol resistance: a familial syndrome and an animal model. (1983) (34)
Low plasma levels of 2-hydrdxyestrone are consistent with its rapid metabolic clearance (1980) (34)
11-Deoxycortisol: a glucocorticoid antagonist in vivo. (1979) (33)
Androstanediol glucuronide isomers in normal men and women and in men infused with labeled dihydrotestosterone. (1988) (32)
Variable efficacy of glucocorticoids in congenital adrenal hyperplasia. (1976) (32)
Plasma steroids in congenital adrenal hyperplasia. (1974) (32)
Rebound thymic hyperplasia after treatment of Cushing's syndrome. (1986) (31)
Radioimmunoassay and metabolic clearance rate of catecholestrogens, 2-hydroxyestrone and 2-hydroxyestradiol in man. (1983) (31)
Relative adrenal insufficiency (2009) (31)
Potency and specificity of a growth hormone-releasing factor in a primate and in vitro. (1984) (30)
Metabolic clearance rate and uterotropic activity of 2-hydroxyestrone in rats. (1981) (30)
Dissociation between cortisol and adrenal androgen secretion in patients receiving alternate day prednisone therapy. (1987) (30)
A comparison of two methods for detecting hormone peaks: the effect of sampling interval on gonadotropin peak frequency. (1984) (30)
Epidemic of gynecomastia among haitian refugees: exposure to an environmental antiandrogen. (2003) (30)
Effects and pharmacokinetic properties of the rat/human corticotropin-releasing factor in rhesus monkeys. (1985) (30)
Effect of hydrocortisone dose schedule on adrenal steroid secretion in congenital adrenal hyperplasia. (1985) (29)
Adrenal androgen secretion in postadolescent acne: increased adrenocortical function without hypersensitivity to adrenocorticotropin. (1991) (28)
Progesterone resistance. (1986) (28)
Rapid regression of fetal adrenal zone and absence of adrenal reticular zone in the marmoset. (1982) (27)
Introduction: The Concept of Stress and Its Historical Development (1988) (27)
Ketoconazole inhibits multiple steroidogenic enzymes involved in androgen biosynthesis in the human ovary. (1988) (27)
Isosexual precocious pseudopuberty secondary to a feminizing adrenal tumor. (1984) (26)
Adrenal function in women with idiopathic acne. (1982) (26)
The effect of ketoconazole on steroidogenesis: I. Leydig cell enzyme activity in vitro. (1988) (26)
Radioligand assay for 5 -3 -hydroxysteroids. II. 5-Androstene-3 ,17 -diol and 3 ,17 -dihydroxy-5-pregnen-20-one. (1972) (25)
Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency. (1987) (25)
Glucocorticoid receptors in Epstein-Barr virus-transformed human lymphocytes. (1985) (25)
Benign bilateral testicular enlargement. (1974) (25)
The effects of estradiol and progesterone on rat ovarian 17-hydroxylase and 3ß-hydroxysteroid dehydrogenase activities (1983) (25)
The effect of short term treatment with growth hormone and ethinyl estradiol on lower leg growth rate in girls with Turner's syndrome. (1988) (25)
Caloric balance, brain to body ratio, and the timing of menarche. (1984) (24)
The Effect of Serum Prolactin on Plasma Adrenal Androgens and the Production and Metabolic Clearance Rate of Dehydroepiandrosterone Sulfate in Normal and Hyperprolactinemic Subjects (1986) (24)
Pulsatile growth hormone secretion in patients with acromegaly and normal men: the effects of growth hormone-releasing hormone infusion. (1990) (24)
"Relative" adrenal insufficiency in critical illness. (2009) (23)
Steroid hormone resistance. Mechanisms and clinical aspects. (1986) (23)
Corticotropin releasing factor: basic and clinical studies. (1983) (23)
Corticotropin-releasing hormone (CRH) stimulation in Nelson's syndrome: response of adrenocorticotropin secretion to pulse injection and continuous infusion of CRH. (1986) (23)
Glucocorticoid receptor in polymorphonuclear leukocytes: a simple method for leukocyte glucocorticoid receptor characterization. (1979) (23)
Diabetes and the Ebers Papyrus: 1552 B.C. (2006) (23)
Effect of the antiprogestin RU486 on human ovarian steroidogenesis. (1987) (23)
Development of glucocorticoid antagonists. (1983) (22)
Evaluation of pituitary gonadotropic function in men: value of luteinizing hormone-releasing hormone response versus basal luteinizing hormone level for discrimination of diagnosis. (1982) (22)
Replacement oral ethinyloestradiol therapy for gonadal dysgenesis: growth and adrenal androgen studies (1979) (22)
Dental Development in Precocious Puberty (1985) (22)
Acute exercise stimulates the renin-angiotensin-aldosterone axis: adaptive changes in runners. (1988) (22)
The effect of osmotic stimuli on prolactin secretion and renal water excretion in normal man and in chronic hyperprolactinemia. (1977) (22)
Growth response relationship between growth hormone dose and short term growth in patients with Turner's syndrome. (1986) (22)
Corticotropin releasing factor: Basic studies and clinical applications (1985) (22)
Burning the Books (1993) (21)
Pharmacology of ovine and human CRH. (1987) (21)
Second-line treatment for Cushing's disease when initial pituitary surgery is unsuccessful (2007) (21)
The effect of the administration of spironolactone on the concentration of plasma testosterone, estradiol and cortisol in male dogs (1978) (21)
Daily administration of the progesterone antagonist RU 486 prevents implantation in the cycling guinea pig. (1991) (20)
Spironolactone stimulation of gonadotropin secretion in boys with delayed adolescence. (1976) (20)
The antiglucocorticoid and antiprogestin steroid RU 486: its glucocorticoid agonist effect is inadequate to prevent adrenal insufficiency in primates. (1988) (20)
A simple specific assay for estriol in maternal urine. (1975) (19)
FSH suppression during short term HCG administration: a gonadally mediated process. (1972) (19)
The effect of 4MA, a potent inhibitor of 5 alpha‐reductase, on the growth of androgen‐responsive human genitourinary tumors grown in athymic nude mice (1987) (19)
The relation between clinical manifestations of polycystic ovary syndrome and β‐cell function (1993) (19)
The incidental adrenal mass (1996) (19)
Effect of the antiglucocorticoid RU486 on adrenal steroidogenic enzyme activity and steroidogenesis. (1994) (18)
Testolactone treatment of precocious puberty in McCune-Albright syndrome. (1985) (18)
Inhibition of dexamethasone binding to human glucocorticoid receptor by New World primate cell extracts (1995) (18)
Luteinizing hormone releasing hormone analogue therapy for central precocious puberty. Long-term effect on somatic growth, bone maturation, and predicted height. (1986) (18)
Failure of breast cancer cells in long-term culture to aromatize androstenedione (1978) (17)
Cortisol resistance in man. (1986) (17)
Cortisol production rates in subjects with suspected Cushing's syndrome: assessment by stable isotope dilution methodology and comparison to other diagnostic methods. (2000) (17)
Steroid and gonadotropin secretion in a patient with a 30-year history of virilization due to lipoid-cell ovarian tumor. (1984) (16)
SAFETY OF CORTICOTROPIN-RELEASING FACTOR (1983) (16)
A chronic, low-dose regimen of the antiprogestin ZK 137 316 prevents pregnancy in rhesus monkeys. (1998) (16)
Normal hypothalamic-pituitary-adrenal axis by high-dose cosyntropin testing in patients with abnormal response to low-dose cosyntropin stimulation: a retrospective review. (2010) (16)
Biobehavioral aspects of precocious puberty. (1986) (16)
Δ1,9(11))-ll-Deoxy cortisol: An Improved Glucocorticoid Antagonist (1980) (16)
Thermal stability of a long-acting analogue of luteinizing hormone releasing hormone (D-trp6-pro9-NEt-LHRH). (1983) (16)
The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease. (1989) (16)
Corticotropin-releasing hormone testing in pituitary disease. (1991) (15)
Adrenal steroid responses to continuous intravenous adrenocorticotropin infusion compared to bolus injection in normal volunteers. (1986) (15)
Hemodynamic and Endocrine Parameters in the Anesthetized Cynomolgus Monkey: A Primate Model (1984) (15)
Steroid biosynthesis in human adrenal tumors. (1987) (15)
Fibroblast androgen receptors in patients with genitourinary anomalies. (1984) (15)
Contraceptive choices for women with endocrine complications. (1993) (14)
Central precocious puberty complicating a virilizing adrenal tumor: treatment with a long-acting LHRH analog. (1985) (14)
The effects of prolactin on rat ovarian function (1984) (14)
Failure of bronchial lavage to detect elevated levels of adrenocorticotropin (ACTH) in patients with ACTH-producing bronchial carcinoids. (1989) (14)
Are catechol oestrogens obligatory mediators of oestrogen action in the central nervous system? I. Characterization of pharmacological probes with different receptor binding affinities and catechol oestrogen formation rates. (1986) (14)
The clinical implications of corticotropin-releasing hormone. (1988) (14)
NIH conference. Clinical applications of corticotropin-releasing factor. (1985) (13)
Does 2-hydroxyestrone suppress prolactin in women? (1982) (13)
An androgen binding protein in the cyst fluid of patients with polycystic ovary syndrome. (1976) (13)
Androgen receptor characteristics in skin fibroblasts from hirsute women. (1985) (13)
Corticotropin-releasing hormone: clinical applications. (1989) (13)
SC 25152: A potent mineralocorticoid antagonist with reduced affinity for the 5 alpha-dihydrotestosterone receptor of human and rat prostate. (1978) (13)
Are catechol oestrogens obligatory mediators of oestrogen action in the central nervous system? II. Potencies of natural and synthetic oestrogens for induction of gonadotrophin release and female sexual behaviour in the rat. (1986) (12)
Adrenal 11-hydroxylase activity in a hypercortisolemic new world primate: Adaptive intra adrenal changes (1987) (12)
A Biographical History of Endocrinology: Loriaux/A Biographical History of Endocrinology (2016) (12)
The effects of temperature on the activity of testicular steroidogenic enzymes (1984) (12)
The effect of ketoconazole on steroidogenesis. II. Adrenocortical enzyme activity in vitro. (1988) (12)
Midluteal phase endometrial biopsy does not accurately predict luteal function. (1993) (12)
A simple, quick, solid-phase method for radioimmunoassay of plasma estradiol and of plasma cortisol of late pregnancy. (1973) (12)
A prospective controlled study of luteal and endometrial abnormalities in an infertile population. (1996) (12)
Effects of catechol estrogen infusions upon gonadotropin and prolactin concentrations in men. (1981) (11)
Improved Quality of Life After Bilateral Laparoscopic Adrenalectomy for Cushing??s Disease (2008) (11)
Diagnosis and Differential Diagnosis of Cushing's Syndrome. (2017) (11)
Effect of cortisol, T3 and T4, on the glucocorticoid receptor concentration in leukocytes. (1980) (11)
The effects of prolactin on rat testicular steroidogenic enzyme activities. (1985) (11)
Neurobiology of Cerebrospinal Fluid 2 (1983) (11)
Characterization of the normal progesterone and placental protein 14 responses to human chorionic gonadotropin stimulation in the luteal phase. (1994) (10)
Δ1-11-oxa-11-deoxycortisol: A new antiglucocorticoid with activity in vivo (1982) (10)
Estrogen and androgen levels in women treated with radiation for cervical cancer--possible influence on breast cancer risk. (1989) (10)
Cerebrospinal Fluid Steroid Hormones (1980) (10)
Catechol estrogens and the control of gonadotropin and prolactin secretion in man. (1983) (10)
Clinical Applications of the Glucocorticoid and Progestin Antagonist RU 486 (1987) (10)
Identification of ACTH-producing intrathoracic tumors by measuring ACTH levels in aspirated specimens. (1987) (9)
Serum adrenal androgens in hyperprolactinaemic women prior to, during, and after chronic treatment with bromocriptine (1982) (9)
The corticotropin releasing factor stimulation test in the evaluation of patients with adrenal insufficiency (1984) (9)
Glucocorticoid receptor-mediated effects on rat fibrosarcoma growth. (1988) (9)
Clinical Studies with Corticotropin Releasing Hormone: Implications for Hypothalamic-Pituitary-Adrenal Dysfunction in Depression and Related Disorders (1988) (8)
A radioimmunoassay of unconjugated oestradiol in urine. (1974) (8)
Late-onset 21-hydroxylase deficiency. (1982) (8)
Corticotropin-releasing factor stimulation test. (2010) (8)
SC 25152: a potent mineralocorticoid antagonist with decreased antiandrogenic activity relative to spironolactone. (1979) (8)
Use of single doses of the antiprogesterone steroid RU 486 for induction of menstruation in normal women. (1985) (8)
The conversion, in vivo, of dehydroepiandrosterone sulfate to testosterone and testosterone glucuronide as reflected in urinary testosterone glucuronide. (1969) (7)
Glucocorticoid antagonists and the role of glucocorticoids at the resting and stress state. (1988) (7)
Pregnancy in a patient with virilizing arrhenoblastoma. (1984) (7)
Production of monoclonal antibodies against human growth hormone releasing hormone and their use in an enzyme-linked immunosorbent assay (ELISA) (1986) (7)
Gonadotrophin and prolactin secretory dynamics in girls with normal puberty, idiopathic precocious puberty and precocious puberty due to hypothalamic hamartoma (1998) (7)
Evidence that synthetic 31-amino acid inhibin-like peptide lacks inhibin activity. (1985) (7)
Dexamethasone therapy for isosexual precocious pseudopuberty caused by generalized glucocorticoid resistance. (1994) (7)
Replacement oral ethinyloestradiol therapy for gonadal dysgenesis: growth and adrenal androgen studies. (1980) (7)
Aristotle (384???322 BC) (2005) (7)
Pituitary Responses to Acute Administration of Thymosin and to Thymectomy in Prepubertal Primates (1984) (6)
Studies on the transfer of steroid hormones across the blood-cerebrospinal fluid barrier in the rhesus monkey. II. (1977) (6)
LHRH analog therapy of precocious puberty (1984) (6)
The contribution of plasma dehydroepiandrosterone sulfate to testosterone in a virilized patient with an arrhenoblastoma. (1970) (6)
Effect of chronic castration on testosterone and estrogen binding to mouse kidney. (1980) (6)
Diabetes: Clinical management (1992) (6)
Growth hormone responses to growth hormone-releasing hormone in Hand-Schüller-Christian Disease. (1989) (6)
Evidence that testosterone and dehydroepiandrosterone sulfate do not contribute to urinary epitestosterone in the stein-leventhal syndrome (1966) (6)
Interaction of RU 486, a glucocorticoid and progestin antagonist with human circulating mononuclear leukocytes. (1989) (5)
Effect of receptor occupancy on [3H]dexamethasone binding to circulating leukocytes. (1980) (5)
Effect of gonadotropin secretion rate on the radiosensitivity of the rat luteinizing hormone-releasing hormone neuron and gonadotroph. (1988) (5)
Endocrine profile of pregnancy in the patas monkey (Erythrocebus patas). (1985) (5)
ACCELERATION OF LINEAR GROWTH AFTER REPEATED DOSES OF GROWTH HORMONE-RELEASING FACTOR (GRF) (1984) (5)
Direct effect of the luteinizing hormone releasing hormone analog D-Trp6-Pro9-Net-LHRH on rat ovarian steroidogenesis. (1985) (5)
Mechanism of precocious puberty in McCune-Albright syndrome (MAS) (1981) (4)
Gonadal and Adrenal Hormone Correlates of Adjustment in Early Adolescence (2021) (4)
Reevaluation of the role of glucocorticoids in surgical stress (1985) (4)
The use of anti-progesterones as a medical IUD. (1988) (4)
The emotional burden of low-risk prostate cancer: proposal for a change in nomenclature. (2006) (4)
Enterohepatic cycling of metabolized testosterone in the male dog. (1965) (4)
Serum adrenal androgens in hyperprolactinaemic women prior to, during, and after chronic treatment with bromocriptine. (1983) (4)
Endocrinology, the Hertz Brothers, and the History of Cancer (2009) (4)
Abnormal growth hormone secretory dynamics in children with familial hypercholesterolemia. (1988) (4)
Effects of the luteinizing hormone-releasing hormone (LHRH) analog D-Trp6-Pro9-NEt-LHRH on the pituitary-gonadal axis of prepubertal rhesus monkeys. (1984) (4)
Jerome w. conn (1907-1994) (2008) (3)
The treatment of Cushing's syndrome and adrenal cancer. (1991) (3)
Comparative analysis of progesterone and placental protein 14 measurements in the evaluation of luteal function. (1993) (3)
Pituitary and gonadal function in the infant son of a patient with hypogonadofropic hypogonadism (1985) (3)
The effects of N,N-diethyl-4-methyl-3-oxo-4-aza-5 alpha-androstane-17 beta-carboxamide, a 5 alpha-reductase inhibitor and antiandrogen, on the development of baldness in the stumptail macaque. (1987) (3)
Pituitary Desensitization with a Long-Acting Luteinizing-Hormone-Releasing Hormone Analog (1983) (3)
The Health Care Mess (1993) (3)
Growth hormone-releasing hormone: therapeutic perspectives. (1987) (3)
Glycine loading test in acute intermittent porphyria patients and their relatives. (1969) (3)
The Old One-Two (1996) (3)
The Use of Boron Neutron Capture for the Treatment of Pituitary Tumors (1993) (2)
Frederick Gowland Hopkins (1861–1947) (2016) (2)
Edward C. Kendall (1886–1972) (2016) (2)
Corticotropin-Releasing Factors (1989) (2)
Corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. (1987) (2)
The relation between clinical manifestations of polycystic ovary syndrome and β-cell function (1993) (2)
Aristotle (384–322 B.C.E.) (2016) (2)
Effects of ketoconazole on rat testicular steroidogenic enzymatic activities. (1985) (2)
A Biographical History of Endocrinology (2016) (2)
RADIOIMMUNOASSAY FOR DEHYDROEPIANDROSTERONE AND ITS SULFATE: EFFECT OF ACTH, GONADOTROPINS AND DEXAMETHASONE ON PLASMA LEVELS (1972) (2)
A Constant Ferment: A History of the Thyroid Clinic and Laboratory at the Massachusetts General Hospital (1992) (2)
Bartolomeo Eustachi (Eustachius) (1520–1574) (2007) (2)
Therapy of precocious puberty: LHRH analogue effects on pubertal growth and maturation (1984) (2)
110 CURRENT MANAGEMENT OF CONGENITAL ADRENAL HYPERPLASIA (CAH): A SURVEY OF THE LAWS0N WILKINS PEDIATRIC ENDOCRINE SOCIETY (LWPES) (1985) (2)
Injections of human corticotropin releasing factor (hCRF) – a rapidly metabolised peptide – cause elevations of plasma ACTH and cortisol that mimic endogenous secretory episodes in man (1985) (2)
Harvey Williams Cushing (1869–1939) (2016) (2)
Frederick Madison Allen, MD: 1879–1964 (2009) (2)
Oskar Minkowski (1858–1931) (2006) (2)
Ovarian steroidogenic enzyme activities during the rat estrous cycle (1982) (2)
Cushing's syndrome. (1994) (1)
Announcement of NIH Conference on "Mechanisms and Clinical Aspects of Steroid Hormone Resistance" (1984) (1)
Sex differences in dental development in children with precocious puberty related to central nervous system lesions. (1986) (1)
Anita H. Payne and Matthew P. Hardy, The Leydig Cell in Health and Disease (2007) (1)
Gonadal and adrenal hormone correlates of self concept in early adolescence (1984) (1)
Direct effect of the luteinizing hormone releasing hormone analog D-Trp6-Pro9-Net-LHRH on rat testicular steroidogenesis (1984) (1)
Timed 12-hour specimens in outpatient estriol monitoring. (1980) (1)
Alfred jost: 1916-1991 (2010) (1)
In memoriam Mortimer B. Lipsett. (1987) (1)
Metablism, Endocrinology and ImmunologyDissociation of Cortisol and Adrenal Androgen Secretion in the Hypophysectomized, Adrenocorticotropin-Replaced Chimpanzee (1985) (1)
Antisera copolymerized with acrylamide. (1975) (1)
Marcello Malpighi: 1628–1694 (2010) (1)
PITUITARY APIASIA IN AN 11 YEAR OLD GIRL: BIOCHEMICAL AND RADIOLOGICAL EVALUATION (1984) (1)
Endocrine Emergencies: Recognition and Treatment (2021) (1)
A preliminary study of the effect of estrogen dose on growth in turner’s syndrome (1984) (1)
Radioimmunoassay of unconjugated estradiol in urine (1974) (1)
The pathophysiology of precocious puberty. (1989) (1)
476 LOW DOSE ESTRADIOL ACCELERATES ULNAR GROWTH IN BOYS (1985) (1)
THE ADRENAL SUPPRESSIVE EFFECT OF HYDROCORTISONE IN CONGENITAL ADRENAL HYPERPLASIA (CAH) IS NOT AFFECTED BY VARYING THE DOSE SCHEDULE (1984) (1)
Rosalyn sussman yalow: 1921 (2010) (1)
William Osler (1849–1919) (2016) (1)
Classics in Endocrinology (1992) (1)
Cushing's: medical approach. (1997) (1)
Potential therapeutic use of a long-acting LHRH analog in idiopathic true precocious puberty (IPP) (1980) (1)
The catechol estrogens: physiologic studies. (1982) (1)
In memoriam: Mortimer B. Lipsett, M.D. (1987) (1)
Robert Burns Woodward (1917–1979) (2009) (1)
Franz leydig (1821-1908) (2007) (1)
49. Leo Loeb and Max Aron (1869–1959) (1892–1974) (2016) (0)
The old one and hyphen;two (1996) (0)
Roy Hertz (1909-2002): Cure of Choriocarcinoma (2016) (0)
Late onset 21-hydroxylase deficiency is a genetic variant of the classic form of congenital adrenal hyperplasia (CAH) (1981) (0)
Corticotropin-releasing hormone (CRH) in the differential diagnosis of Cushing's syndrome: Introduction to symposium proceedings (1997) (0)
Grant Liddle (1921–1989) (2005) (0)
Frederick Grant Banting (1891–1941) (2016) (0)
Monte Arnold Greer (1922–2002) (2016) (0)
George washington corner 1889–1981 (2016) (0)
Philip E. Smith (1884–1970) (2016) (0)
Eating the seed corn (1995) (0)
Sir James Paget (1814–1899) (2016) (0)
Long term culture of human tumor cells from malignant effusions as a tool for individualizing chemotherapy (1975) (0)
REPLACEMENT DOSES OF GLUCOCORTICOIDS. REPLY (1991) (0)
99. Rosalyn Sussman Yalow (1921–2011) (2016) (0)
Acquired refractoriness to growth hormone in a patient with isolated growth hormone deficiency: growth and plasma somatomedin-C response to high-dose growth hormone therapy. (1984) (0)
Testosterone metabolic clearance rate and production rate in the male infant rhesus monkey. (1985) (0)
Adolphe Chatin (1813–1901) (2016) (0)
What is the origin of excessive estrone in alcoholics (1978) (0)
Delta 1,9(11)-11-deoxycortisol: an improved glucocorticoid antagonist. (1980) (0)
James Bertram Collip (1893–1965) (2016) (0)
23. Armand Trousseau (1801–1867) (2016) (0)
Robert McCarrison (1878–1960) (2016) (0)
46. George R. Murray (1865–1939) (2016) (0)
Improved Quality of Life After Bilateral Laparoscopic Adrenalectomy for Cushing's Disease. Authors' reply (2008) (0)
Forthcoming papers (1985) (0)
Jacob Robbins, MD: 1923–2008 (2009) (0)
Saul Hertz (1905–1950) (2016) (0)
100. Mort Lipsett (1921–1984) (2016) (0)
97. Sylvia Agnes Sophia Tait (1917–2003) (2016) (0)
Archibald Edward Garrod (1857–1936) (2016) (0)
Gerty and Carl Cori (1896–1957) (1896–1984) (2016) (0)
106. John Doppman (1928–2000) (2016) (0)
Variable efficacy of glucocorticoids (GC) in congenital adrenal hyperplasia (CAH) (1973) (0)
Earl W. Sutherland (1915–1974) (2016) (0)
Claude Bernard 1813–1878 (1991) (0)
101. Griff Terry Ross (1921–1985) (2016) (0)
Frederic c. bartter (1914-1983) (2006) (0)
505 ANDROGEN LEVELS IN AN INFANT WITH KLINEFELTER'S SYNDROME (1985) (0)
"The Progesterone Antagonist RU 486: A Potential New Contraceptive Agent" (1987) (0)
92. Frederic C. Bartter (1914–1983) (2016) (0)
21 TIMING OF ADRENARCHE AMD GONADARCHE AND PSYCHOLOGICAL ADJUSTMENT NORMAL ADOLESCENTS (1985) (0)
Richard lower: 1631-1691 (2010) (0)
MECHANISM OF PRECOCIOUS PUBERTY IN GIRLS WITH McCUNE-ALBRIGHT SYNDROME (MAS) (1984) (0)
Use of the Glucocorticoid Antagonist RU 486 in the Treatment of Cushing’s Syndrome (1985) (0)
Dorothy Price and Carl Moore (1899–1980) (1892–1955) (2016) (0)
Contraceptive choices for women with endocrine complications (1994) (0)
Frederick Madison Allen (1879-1964): The Diabetic Diet (2016) (0)
Functioning disorders of the adrenal gland: a symptom-orientated approach. (1994) (0)
William Bayliss and Ernest Starling (1860–1924) (1866–1927) (2016) (0)
Mort Lipsett (1921–1984) (2005) (0)
Thomas Addison (1795–1860) (2016) (0)
28. Sir William Gull (1816–1890) (2016) (0)
William Harvey (1578–1657) (2016) (0)
Russell earl marker (1902-1995) (2008) (0)
John J. Abel (1857–1938) (2016) (0)
Measurement of human cortisol production rate by isotope dilution thermospray LC/MS (1988) (0)
Geoffrey W. Harris (1913–1967) (2016) (0)
The mechanism of hypercortisolemia in squirrel monkeys (1981) (0)
Roger Guillemin and Andrew Schally (1924–) (1926–) (2016) (0)
Attempted Prevention of Abnormal External Genital Masculinization in Suspected Congenital Adrenal Hyperplasia (2017) (0)
Gregory Goodwin Pincus (1903–1967) (2016) (0)
38. William Stewart Halsted (1852–1922) (2016) (0)
Frederick L. Hisaw (1891–1972) (2016) (0)
Moses Barron: 1883–1974 (2009) (0)
Charles Robert Harington (1897–1972) (2016) (0)
389 LONGITUDINAL STUDY OF TESTICULAR VOLUME DURING EARLY INFANCY (1981) (0)
59. Henry H. Dale (1875–1968) (2016) (0)
Frank G. Young (1908–1988) (2016) (0)
The cortisol production rate in children: Implications for therapy (1991) (0)
Fuller Albright (1900–1969) (2016) (0)
41. Victor Horsley (1857–1916) (2016) (0)
79. LHRH analog therapy in boys with true precocious puberty due to hypothalamic hamartoma (1982) (0)
David Marine (1880–1976) (2016) (0)
W.G. MacCallum (1874–1944) (2016) (0)
John Hunter (1728–1793) (2016) (0)
G.F. Marrian (1904–1981) (2016) (0)
4. Hippocrates (400 B.C.E) (2016) (0)
102. Grant Liddle (1921–1989) (2016) (0)
219. Hypothalamic and pituitary levels of 2-hydroxyestrogens during estrogen loading and gonadotropin suppression in rats (1982) (0)
Solomon Berson April 22, 1918-April 11, 1972 (1995) (0)
J.J.R. Macleod (1876–1935) (2016) (0)
An approach to the patient with hirsutism: Editorial comment (2013) (0)
Metabolism behavior of glucocorticoid and progesterone antagonist steroid RU 486 in the human. (1988) (0)
Griff Terry Ross (1921–1985) (2005) (0)
35. Enrico Sertoli (1842–1910) (2016) (0)
Thomas Wharton (1614–1673) (2016) (0)
Roy Hertz (1909–2002) (2004) (0)
22. Robert James Graves (1796–1853) (2016) (0)
The case report (1992) (0)
88. Dorothy Crowfoot Hodgkin (1910–1994) (2016) (0)
Local effects of cortisol on testicular function in rats (1994) (0)
Emil Fischer (1852–1919) (2016) (0)
Berta and Ernst Scharrer (1906–1995) (1905–1965) (2016) (0)
Donald S. Fredrickson (1924–2002) (2008) (0)
Mechanism of luteinizing hormone (LH) and testosterone (T) suppression by fluoxymesterone (Halotestin) (1975) (0)
Dorothy crowfoot hodgkin: 1910-1994 (2010) (0)
Gerald Aurbach (1927–1991) (2016) (0)
Charles Brenton Huggins (1901???1997) (2005) (0)
Activity of adrenal enzymes in a child with Cushing's syndrome and micronodular adrenal disease (1989) (0)
Enrico Sertoli (1842–1910) (2009) (0)
68. Henry H. Turner (1892–1970) (2016) (0)
Corticotropin Releasing Factor (Hormone): Physiological and Clinical Implications (1989) (0)
Elliott proctor joslin (1869-1962) (2006) (0)
Jacob Robbins (1923–2008) (2016) (0)
Herbert McLean Evans (1882–1971) (2016) (0)
A shot in the foot (1992) (0)
74. Charles Brenton Huggins (1901–1997) (2016) (0)
Delayed endometrial maturation incuded by daily administration of the antiprogestin RU 486: A potential new contraceptive strategy (1993) (0)
International Society of Endocriology (2004) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Donald L. Loriaux?

Donald L. Loriaux is affiliated with the following schools:

University of British Columbia
Oregon Health & Science University

Donald L. Loriaux's Academic­Influence.com Rankings

Why Is Donald L. Loriaux Influential?

Donald L. Loriaux's Published Works

Published Works

What Schools Are Affiliated With Donald L. Loriaux?

Donald L. Loriaux's AcademicInfluence.com Rankings